Clinical Trial Update: Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout [Phase 1]

View source ↗

Summary

A Phase 1 study investigating approaches to recapture immune tolerance to pegloticase for treating tophaceous gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tophaceous Gout

Drugs mentioned

• KRYSTEXXA (pegloticase)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Tophaceous Gout | Phase 1 | Status: COMPLETED